HonorHealth

Summary

HonorHealth is a medical facility located in Scottsdale, Arizona. This center is recognized for care of Solid Tumors, Cancer, Pancreatic Cancer, Lung Cancer, Ovarian Cancer and other specialties. HonorHealth is involved with conducting 141 clinical trials across 318 conditions. There are 17 research doctors associated with this hospital, such as Michael S Gordon, MD, Sunil Sharma, Erkut Borazanci, MD, and Justin Moser, MD.

Top PIs

Clinical Trials running at HonorHealth

Pancreatic Cancer

Non-Hodgkin's Lymphoma

Ovarian Cancer

Heart Failure

Cancer

Prostate Cancer

Solid Tumors

Lymphoma

Breast Cancer

Lung Cancer

FOG-001

for Cancer

This trial is testing FOG-001, a new medicine, to see if it is safe and effective for patients with advanced or spreading solid tumors. FOG-001 works by blocking certain proteins to stop cancer cells from growing.

Recruiting

1 award

Phase 1 & 2

8 criteria

LY4170156

for Breast Cancer

The purpose of this study is to find out whether the study drug, LY4170156, is safe, tolerable and effective in participants with advanced solid tumors. The study is conducted in two parts - phase Ia (dose-escalation, dose-optimization) and phase Ib (dose-expansion). The study will last up to approximately 4 years.

Recruiting

1 award

Phase 1

1 criteria

WTX-124 + Pembrolizumab

for Solid Tumors

This trial tests a new medicine called WTX-124, alone and with pembrolizumab, in patients with severe forms of skin and kidney cancer. WTX-124 helps the immune system attack cancer cells, and pembrolizumab makes it easier for the immune system to see these cells.

Recruiting

1 award

Phase 1